Record and Chart Peak Flow Readings and Asthma SymptomsMy Health Software
Boggs PB. Peak expiratory flow rate control chart: a breakthrough in asthma care. Ann Allergy Asthma Immunol 1996;77:429-32.Boggs PB. Peak expiratory flow rate control chart: a breakthrough in asthma care [editorial]. Ann Allergy Asthma Immunol 1996;77:429- 33....
Methods: Information from literature and interviews with 12 respiratory physicians (four each from France, Spain and UK) and 46 asthma patients was obtained. Factors affecting adherence to asthma treatment were identified, reviewed and a flow chart developed to indicate the relationship between key ...
Barriers that affected self-efficacy included lack of office time to properly measure peak flow, inadequate staff or physician training, and poor follow-up to use PFM readings. Low outcome expectancy was mentioned in relation to poor patient compliance. Furthermore, patients were not always able ...
In addition, From 1993 to 2022, We can see the number of articles in Figure 1 had been in a growth pattern, reaching a peak in the past two years. Furthermore, in order to further evaluate the changing trend of CVA studies, the linear function Y=1.6885X-0.4391(...
Morning and evening peak expiratory flow SFC: Salmeterol/fluticasone propionate combination References Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis. 1981;123:413–7. CA...
Diary data, Asthma Control Questionnaire scores, forced expiratory volume in 1 second (FEV1), and peak expiratory flow (PEF) measurements were collected during run-in and after 1, 3, 6, and 12 months of treatment. BHR, measured as the dose of histamine provoking a fall in FEV1 of 20% ...
• Measurements of lung function (spirometry or peak expiratory flow) provide an assessment of the severity of airflow limitation, its reversibility, and its variability, and provide confirmation of the diagnosis of asthma. • Measurements of allergic status can help to identify risk factors that...
Table 3. ± Investigation of difficult/therapy-resistant asth- ma Assessment of severity Symptom score chart and use of b2-agonist reliever therapy Spirometric measurement of lung volumes and gas transfer Bronchial responsiveness to methacholine/histamine Diurnal variation in peak expiratory flow Quality ...
In the AIR Trial, at 12 months post-treatment, while patients were on ICS alone, these benefits included significantly greater improvements in the BT group than in the Control group in mild exacerbation rates, morning peak expiratory flow, scores on the AQLQ and ACQ, the percentage of symptom...